These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15029154)

  • 1. Making data dreams come true.
    Nature; 2004 Mar; 428(6980):239. PubMed ID: 15029154
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene.
    Gottesman MM; Pastan IH
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26286731
    [No Abstract]   [Full Text] [Related]  

  • 3. New opportunities for uncovering the molecular basis of cancer.
    Strausberg RL; Dahl CA; Klausner RD
    Nat Genet; 1997 Apr; 15 Spec No():415-6. PubMed ID: 9140408
    [No Abstract]   [Full Text] [Related]  

  • 4. Efforts aimed at reducing noise, data overload in microarrays.
    Tuma RS
    J Natl Cancer Inst; 2005 Aug; 97(16):1173-5. PubMed ID: 16106018
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatics in research and clinical practice.
    Nadon R; Sladek R
    Clin Invest Med; 2003 Apr; 26(2):75-7. PubMed ID: 12722840
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioinformatics: implications for medical research and clinical practice.
    Lynn DJ; Lloyd AT; O'Farrelly C
    Clin Invest Med; 2003 Apr; 26(2):70-4. PubMed ID: 12722839
    [No Abstract]   [Full Text] [Related]  

  • 7. Incorporating computational resources in a cancer research program.
    Woods NT; Jhuraney A; Monteiro AN
    Hum Genet; 2015 May; 134(5):467-78. PubMed ID: 25324189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics: Marked for success.
    Ledford H
    Nature; 2012 Mar; 483(7391):637-9. PubMed ID: 22468273
    [No Abstract]   [Full Text] [Related]  

  • 9. A revolutionary landscape: the restructuring of biology and its convergence with medicine.
    Kafatos FC
    J Mol Biol; 2002 Jun; 319(4):861-7. PubMed ID: 12079311
    [No Abstract]   [Full Text] [Related]  

  • 10. A gene expression database for the molecular pharmacology of cancer.
    Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
    Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SLAMS dunk for cancer regulators.
    Kumar-Sinha C; Chinnaiyan AM
    Nat Biotechnol; 2006 May; 24(5):524-6. PubMed ID: 16680134
    [No Abstract]   [Full Text] [Related]  

  • 12. Duke scandal highlights need for genomics research criteria.
    Goozner M
    J Natl Cancer Inst; 2011 Jun; 103(12):916-7. PubMed ID: 21693754
    [No Abstract]   [Full Text] [Related]  

  • 13. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer: Reshaping the cancer clinic.
    Schmidt C
    Nature; 2015 Nov; 527(7576):S10-1. PubMed ID: 26536216
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics and personalized medicine.
    Meadows M
    FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin.
    Dabholkar M; Reed E
    Cancer Chemother Biol Response Modif; 1996; 16():88-110. PubMed ID: 8639408
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cancer dependencies from expression data using deep learning.
    Itzhacky N; Sharan R
    Mol Omics; 2021 Feb; 17(1):66-71. PubMed ID: 33135031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [cDNA microarray technology as a laboratory examination method: a gene expression profiling test for analysis of drug resistance in tumor cells].
    Miyachi H; Kobayashi H; Asai S; Shinbata T; Arami S; Mitsuse S
    Rinsho Byori; 2002 Feb; 50(2):161-8. PubMed ID: 11925854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
    Horswell S; Matthews N; Swanton C
    Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.